Tofanib (XELJANZ) Tofacitinib 5mg online

Tofanib (XELJANZ) is an inhibitor of Janus kinases (JAKs) indicated for the treatment of :

1. Adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).

2.Adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).

3. Limitations of Use: Use of Tofanib (XELJANZ) in (combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

DOSAGE AND ADMINISTRATION

1.Rheumatoid Arthritis

•        Recommended dose of Tofanib (XELJANZ) is 5 mg twice daily.
•        Recommended dose of Tofanib XR (XELJANZ XR) is 11 mg once daily.
•        Recommended dose in patients with moderate and severe renal impairment and moderate hepatic impairment is Tofanib (XELJANZ)5 mg once daily.
•        Use of Tofanib (XELJANZ)/ Tofanib XR (XELJANZ XR) in patients with severe hepatic impairment is not recommended.

2.Psoriatic Arthritis

•        Recommended dose of Tofanib (XELJANZ) is 5 mg twice daily, used in combination with nonbiologic DMARDs.
•        Recommended dose of Tofanib XR (XELJANZ XR) is 11 mg once daily, used in combination with nonbiologic DMARDs.
•        Recommended dose in patients with moderate and severe renal impairment and moderate hepatic impairment is Tofanib (XELJANZ)5 mg once daily.
•        Use of Tofanib (XELJANZ)/ Tofanib XR (XELJANZ XR) in patients with severe hepatic impairment is not recommended.

Tofanib’s brand name is XELJANZ®by Pfizer Labs. Tofanib is an inhibitor of Janus kinases from Globe Pharmaceuticals, which is one of the biggest pharmaceutical company in Bangladesh.

For more Prescribing information，please check the → “FDA Prescribing Information”.

139.00 per 30 Tablets